How can we Identify Do-Not-Do Treatments? - CLL Support

CLL Support

22,503 members38,652 posts

How can we Identify Do-Not-Do Treatments?

AussieNeil profile image
AussieNeilAdministrator
1 Reply

"For decades, clinicians and researchers have been concerned about patients getting treatments, including operations, that don’t work. As well as failing to treat the original health problem, ineffective care exposes patients to complications and side-effects and waste precious health-care resources."

While not about CLL or even cancer, this article by Peter Breadon and Stephen Duckett at Australia's Grattan Institute, show how reporting of treatment by condition can be analysed to identify which treatments may be ineffective. In particular, look at the graph "Some public hospitals give do-not-do treatments far more often than average" and read the accompanying discussion, which shows the value that can be gained from analysing reporting of treatment by condition.

NICE UK also gets a mention for its work in identifying treatments that evidence shows should not be given to certain types of patient.

Neil

Photo: White headed/black winged stilts cruising around a popular skiing lake.

Written by
AussieNeil profile image
AussieNeil
Administrator
To view profiles and participate in discussions please or .
1 Reply
Cllcanada profile image
CllcanadaTop Poster CURE Hero

The BEER's list has been recently updated... worth a look... drugs not suitable for all geriatric patients...

americangeriatrics.org/file...

You may also like...

Just not sure what we can and can't do

is 68. We have been told by a health worker (not connected to my treatment) that we should not be...

HOW DO WE DETERMINE MUTATION STATUS?

Identifying Skin Cancers

Because CLL patients are susceptible to secondary cancers including skin cancers. It is important to

Looks like here we go again...to treatment.

the hospital, after being admitted in serious condition. I was treated with a combination of...

Potential Early Drivers of Disease in Treatment-Naive CLL Identified

features with time-to-first treatment (TTFT), study researchers identified potential early drivers...